Condition: Breast Cancer · Sponsor: Centre Henri Becquerel
The purpose of this study is to determine if pharmacokinetics of docetaxel is modified by the body composition (assessed by the BMI but also by CT-scan) in patients treated by docetaxel as adjuvant treatment of a localized breast cancer
This description comes directly from the study's public registry record.
Florian Clatot, Prof · +33232082231 · florian.clatot@chb.unicancer.fr
Doriane Richard, PhD · +33232082985 · doriane.richard@chb.unicancer.fr
Always discuss trial participation with your own doctor first.
| Centre Henri Becquerel | Rouen, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05858398